JOSE DE LEON: Open Payments
NPI 1003024944 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 21 payments from 15 companies in 2025. Trend: 2023 $48 · 2024 $115 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Neurocrine BioSciences, Inc. | 2 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Corcept Therapeutics | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
Products named: REXULTI, INGREZZA, AIRSUPRA, GEMTESA, JARDIANCE, MOUNJARO, Korlym, VRAYLAR.
Industry payments across TX — which companies pay providers there.
